Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL228836 | 0.86 | LMNA (0.31) | LMNACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL5919710 | 0.84 | LMNA (0.32) | LMNACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL5176984 | 0.83 | GRIK1 (0.37) | LMNACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL8463146 | 0.82 | MAPT (0.33) | MAPT | |
| SCHEMBL224781 | 0.77 | — | — | |
| SCHEMBL5079129 | 0.73 | CTSK (0.30) | — | |
| SCHEMBL7116269 | 0.71 | ALOX15 (0.38) | LMNATSHRALOX15 | |
| SCHEMBL871939 | 0.71 | — | — | |
| SCHEMBL28666266 | 0.71 | — | — | |
| SCHEMBL28409399 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4176721-A1 | BIOCIDAL POLYMER BLENDS | LANXESS Deutschland GmbH (DE) | 2023-05-10 | — | — | EP | claimed |
| CN-102202510-B | Antisapstain compositions comprising a haloalkynyl compound, an azole and an unsaturated acid | ARCH TIMBER PROTECTION LTD | 2015-05-20 | — | — | CN | claimed |
| CN-102202510-A | Antisapstain compositions comprising a haloalkynyl compound, an azole and an unsaturated acid | ARCH TIMBER PROTECTION LTD | 2011-09-28 | — | — | CN | claimed |
| US-7943644-B2 | Stabilization of iodine-containing biocides by means of special azole compounds | LANXESS DEUTSCHLAND GMBH (DE) | 2011-05-17 | — | — | US | claimed |
| CN-119907836-A | Copper-containing compounds and compositions for antimicrobial paints and coatings | 阿萨达有限责任公司 | 2025-04-29 | — | — | CN | disclosed |
| WO-2023078794-A1 | BIOCIDAL POLYMER BLEND | LANXESS DEUTSCHLAND GMBH (DE) | 2023-05-11 | — | — | WO | disclosed |
| EP-4176721-A1 | BIOCIDAL POLYMER BLENDS | LANXESS Deutschland GmbH (DE) | 2023-05-10 | — | — | EP | disclosed |
| US-20130045241-A1 | STABILIZED AQUEOUS DISPERSION OF FOLPET ANALOGUES, METHOD OF PREPARING THE SAME AND COMPOSITION THEREOF | ISP INVESTMENTS INC. (US) | 2013-02-21 | — | — | US | disclosed |
| CN-102202510-A | Antisapstain compositions comprising a haloalkynyl compound, an azole and an unsaturated acid | ARCH TIMBER PROTECTION LTD | 2011-09-28 | — | — | CN | disclosed |
| WO-2011071876-A1 | STABILIZED AQUEOUS DISPERSION OF FOLPET ANALOGUES, METHOD OF PREPARING THE SAME AND COMPOSITION THEREOF | ISP INVESTMENTS INC. (US) | 2011-06-16 | — | — | WO | disclosed |
| US-7943644-B2 | Stabilization of iodine-containing biocides by means of special azole compounds | LANXESS DEUTSCHLAND GMBH (DE) | 2011-05-17 | — | — | US | disclosed |
| US-20090192219-A1 | STABILIZATION OF IODINE-CONTAINING BIOCIDES BY MEANS OF SPECIAL AZOLE COMPOUNDS | LANXESS DEUTSCHLAND GMBH (DE) | 2009-07-30 | — | — | US | disclosed |
| US-20090036555-A1 | Stabilization of iodine biocides | LANXESS DEUTSCHLAND GMBH (DE) | 2009-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130045241-A1 | STABILIZED AQUEOUS DISPERSION OF FOLPET ANALOGUES, METHOD OF PREPARING THE SAME AND COMPOSITION THEREOF | PCMT1, BLVRB, DHFR | LMNA 4012/4885CHRM2 4488/4885CHRM4 4645/4885 |
| US-20090036555-A1 | Stabilization of iodine biocides | LCT, BTD, HDHD5 | LMNA 4349/4885CHRM2 4874/4885CHRM4 4875/4885 |
| US-20090192219-A1 | STABILIZATION OF IODINE-CONTAINING BIOCIDES BY MEANS OF SPECIAL AZOLE COMPOUNDS | LCT, BTD, ALKBH3 | LMNA 4261/4885CHRM2 4796/4885CHRM4 4692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.